Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 503,000
-12,000 (-2.33%)
Sep 18, 2026, 3:30 PM KST
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 6.38 trillion as of September 18, 2026. Its market cap has increased by 61.33% in one year.
Market Cap
6.38T
Enterprise Value
6.58T
Revenue
1.66T
Ranking
n/a
PE Ratio
29.42
Stock Price
503,000.00
ChartMarket Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 6.38T, an increase of 837.66%. That is a compound annual growth rate of 14.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 6.38T | 11.36% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 5.66T |
| Hanall Biopharma | 2.42T |
| Celltrion Pharm | 1.73T |
| GC Biopharma | 1.40T |
| Daewoong Pharmaceutical | 1.26T |
| Chong Kun Dang Pharmaceutical | 840.63B |
| Boryung | 694.04B |
| Daewoong | 660.40B |